Search

everythinglearnresearchcommunity

for

Search:↓

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

We need safe, affordable drugs to fight coronaviruses effectively.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

Long COVID is a big health problem needing more research and better treatments.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Women are more likely to have long-term post-COVID symptoms than men.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.